Ryancoates (Talk | contribs) |
Ryancoates (Talk | contribs) |
||
Line 52: | Line 52: | ||
<br><br> | <br><br> | ||
<h3>5.Public Interaction and Human Practices</h3><br> | <h3>5.Public Interaction and Human Practices</h3><br> | ||
− | <p>We conducted a <a href="https://2017.igem.org/Team:Cardiff_Wales/Survey">survey</a> for almost 300 participants that assessed public opinion on the use of genetic modification for the production of pharmaaceuticals in animals or plants.<br> We also discussed with a range of experts the scientific and economic advantages of using plants for protein production. This allowed us to perform an analysis on the benefits of the plant expression system, which integrated with our modelling work. This can be found on <a href="https://2017.igem.org/Team:Cardiff_Wales/Our_research">Our Research</a> page. | + | <p>We conducted a <a href="https://2017.igem.org/Team:Cardiff_Wales/Survey">survey</a> for almost 300 participants that assessed public opinion on the use of genetic modification for the production of pharmaaceuticals in animals or plants.<br> We also discussed with a range of experts the scientific and economic advantages of using plants for protein production. This allowed us to perform an analysis on the benefits of the plant expression system, which integrated with our modelling work. This can be found on <a href="https://2017.igem.org/Team:Cardiff_Wales/Our_research">Our Research</a> page.<br><br> |
</div> | </div> | ||
<div class="column_full_size"/> | <div class="column_full_size"/> |
Revision as of 18:40, 30 October 2017